AaveFlash establishes deep partnership with Aave, becoming exclusive liquidity provider for V3-level users
According to ChainCatcher, as announced on its official X platform, the decentralized finance project AaveFlash has reached a deep cooperation with the Aave ecosystem, becoming the exclusive liquidity provider for Aave V3-level users. The project is committed to building a global capital network centered on intelligent liquidity aggregation, AI strategy scheduling, and a capital engine.
AaveFlash stated that its goal is to make complex professional operations such as arbitrage, liquidation, and market making more accessible, enabling ordinary users to easily participate in global capital flows and profit distribution. The team will launch a limited edition of 999 node NFTs as proof of ecosystem co-builders. Holders will enjoy governance, dividends, airdrop priority, and global partner status.
Currently, DeFi total value locked continues to rebound, and the integration of RWA and AI finance is accelerating. AaveFlash said that during this cycle, it will launch a global node co-building plan, inviting strategic partners and communities from around the world to jointly build an open and autonomous flash ecosystem.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Janus Henderson Macro Head Says Market Is Near Its Top but Cannot Say When
A $5.7 billion patent verdict has been issued, Burford Capital (BUR.US) may receive $1.4 billion, and its share price soared by more than 12%.
Burford Capital Ltd. surged more than 12% on Monday, marking its largest intraday increase since the end of March, after a federal jury delivered a verdict in a patent case involving Apple.
Pfizer (PFE.US), BioNTech (BNTX.US), and Moderna (MRNA.US) seek dismissal of Bayer’s Monsanto mRNA patent lawsuit, but the judge rejects the request
A federal judge in Delaware on Monday rejected the requests from Pfizer, BioNTech, and Moderna to dismiss a lawsuit filed against them by Monsanto, a subsidiary of the German pharmaceutical giant Bayer. The lawsuit concerns these pharmaceutical companies' use of a patent related to mRNA technology.
After years of waiting and another delay, Tesla (TSLA.US) postpones the Roadster debut to October 15 as severe weather forces the event to stop.
Tesla has rescheduled the unveiling event for its next-generation Roadster, originally planned for this week, to October 15.
Crypto prices
More
